People born with a deficit of alpha-1 antitrypsin

Emphysema is a type of chronic lasix 4 mg obstructive pulmonary disease (), which primarily affects the exchange of air spaces (alveoli) in lungs. It destroys the walls of the alveoli, leading to increased, irregular airspace, which is very inefficient in the absorption of oxygen in the blood and releasing carbon dioxide from the blood. Small airways and fall on exhalation, resulting in airway obstruction and air becomes trapped in the lungs. Emphysema is often caused by chronic effects of inhalation of harmful gases. Smoking is the main cause. Of course, not all smokers develop emphysema, but there is no test that can predict which smokers are most exposed to the development of this disease. People with emphysema usually also have some degree or chronic asthmatic bronchitis. In addition to associated with smoking, emphysema, is also inherited type of emphysema called alpha-1 antitrypsin (AAT) deficiency-related emphysema. This type of emphysema is associated with mutation of the gene leads to absence of protective protein AAT. Under normal conditions, AAT panels lung neutrophil elastase natural enzyme that helps fight bacteria and destroy damaged lung tissue. If this enzyme is neutralized by AAT, it eventually can damage healthy lung tissue. In people with hereditary AAT deficiency do not have enough to neutralize the AAT neutrophilic elastase, an enzyme related damage can quickly lead to emphysema. Smoking is the cause of emphysema in part because tobacco smoke inactivates AAT. Risk: Smoking is a common risk factor for the disease and ranges from 80% to 90% of COPD, including emphysema (American Lung Association). Men over age 40 who smoke, have high risk of developing emphysema, although the annual increase among women (InteliHealth). Influence of tobacco smoke and air toxins increase the risk of the disease. People born with a deficit of alpha-1 antitrypsin (AAT) have a higher risk of developing emphysema. This mutation is most common in northern white European origin (InteliHealth). Incidence and prevalence: There are about 3 million cases of smoking-related emphysema diagnosed in the United States. Approximately 50,000 to 100,000 people have AAT deficiency-related emphysema (American Lung Association). COPD (including emphysema and to a lesser extent, asthmatic bronchitis) is the fourth leading cause of death in the U.S. (Klyaynshmidt). .